Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 18, 2022

SELL
$72.36 - $113.1 $690,169 - $1.08 Million
-9,538 Reduced 0.94%
1,009,266 $73 Million
Q2 2022

Jul 25, 2022

BUY
$87.2 - $114.05 $2.53 Million - $3.3 Million
28,978 Added 2.93%
1,018,804 $109 Million
Q1 2022

Apr 25, 2022

BUY
$94.19 - $124.49 $435,440 - $575,517
4,623 Added 0.47%
989,826 $110 Million
Q4 2021

Jan 18, 2022

BUY
$119.57 - $139.07 $11.2 Million - $13 Million
93,822 Added 10.53%
985,203 $126 Million
Q3 2021

Nov 05, 2021

SELL
$109.17 - $142.35 $8.14 Million - $10.6 Million
-74,564 Reduced 7.72%
891,381 $119 Million
Q2 2021

Jul 28, 2021

BUY
$100.34 - $115.69 $1.07 Million - $1.23 Million
10,675 Added 1.12%
965,945 $104 Million
Q1 2021

May 24, 2021

BUY
$101.51 - $125.27 $97 Million - $120 Million
955,270 New
955,270 $101 Million
Q1 2021

May 03, 2021

SELL
$101.51 - $125.27 $214,896 - $265,196
-2,117 Closed
0 $0
Q4 2020

Jan 21, 2021

SELL
$85.88 - $105.36 $56,251 - $69,010
-655 Reduced 23.63%
2,117 $220,000
Q2 2020

Aug 07, 2020

BUY
$48.02 - $79.04 $16,855 - $27,743
351 Added 14.5%
2,772 $203,000
Q1 2020

May 04, 2020

BUY
$36.95 - $62.95 $28,857 - $49,163
781 Added 47.62%
2,421 $125,000
Q4 2019

Feb 06, 2020

BUY
$47.06 - $56.64 $77,178 - $92,889
1,640 New
1,640 $92,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Pendal Group LTD Portfolio

Follow Pendal Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.